Skip to main content
Ribicon Pharma
About
Products
Solid-Tumor Biomarkers
  • Alpha-fetoprotein (AFP)
  • CA-125
  • Gastric Carcinoma GC-REAAD
  • Hepatocellular Carcinoma HCC-REAAD
  • Nasopharyngeal Carcinoma NPC-REAAD
Targeted Therapeutics
  • Tepadina (thiotepa)
  • Phelinun (melphalan)
Ophthalmology
  • Bimatoprost eye drops
  • Latanoprost eye drops
Cardiology
  • Vectraplex ECG
  • Troponin test
Veterinary Diagnostics
    Infant Formulas & Children’s Food
      ServicesContact
      FR/EN
      Partner with us

      Legal information

      Privacy

      This staging privacy notice is a content placeholder and must be reviewed against Ribicon Pharma’s actual data practices before launch.

      Information you choose to provide

      If you contact Ribicon Pharma by email, the company may receive your name, contact information, organization, and message. Do not include personal health information in a general inquiry.

      Purpose and retention

      Information should be used only to respond to the stated inquiry and retained only as long as required for that purpose and any applicable legal obligations.

      Before launch

      Ribicon Pharma must identify its privacy officer, service providers, hosting region, analytics choices, retention periods, cross-border transfers, and procedures for privacy requests before this notice is finalized.

      Ribicon Pharma

      Specialized healthcare, thoughtfully brought to market.

      Explore

      AboutPortfolioServices

      Contact

      Montréal, Québec, Canada

      info@ribicongroup.com

      Information

      PrivacyAccessibility

      © 2026 Ribicon Pharma. All rights reserved.

      Information on this website is not medical advice.